Dr. Paul D. Harker-Murray
Claim this profileChildren's Hospital of Wisconsin
Expert in Tumors
Expert in Brain Tumor
19 reported clinical trials
26 drugs studied
Area of expertise
1Tumors
Global LeaderStage I
Stage II
MTOR positive
2Brain Tumor
Global LeaderStage I
Stage II
MTOR positive
Affiliated Hospitals
Clinical Trials Paul D. Harker-Murray is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Auricular Neurostimulation
for Chemotherapy-Induced Nausea and Vomiting
This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.
Recruiting0 awards N/A
More about Paul D. Harker-Murray
Clinical Trial Related7 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Paul D. Harker-Murray has experience with
- Laboratory Biomarker Analysis
- Questionnaire Administration
- Erdafitinib
- Olaparib
- Palbociclib
- Selpercatinib
Breakdown of trials Paul D. Harker-Murray has run
Tumors
Brain Tumor
Recurrence
Langerhans Cell Histiocytosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul D. Harker-Murray specialize in?
Paul D. Harker-Murray focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Paul D. Harker-Murray currently recruiting for clinical trials?
Yes, Paul D. Harker-Murray is currently recruiting for 3 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Paul D. Harker-Murray has studied deeply?
Yes, Paul D. Harker-Murray has studied treatments such as Laboratory Biomarker Analysis, Questionnaire Administration, Erdafitinib.
What is the best way to schedule an appointment with Paul D. Harker-Murray?
Apply for one of the trials that Paul D. Harker-Murray is conducting.
What is the office address of Paul D. Harker-Murray?
The office of Paul D. Harker-Murray is located at: Children's Hospital of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Children's Hospital of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.